About half of the 93 million CT exams performed in the U.S. in 2023 used IV contrast, and volume is expected to keep climbing. At that scale, contrast is an operational resource as much as a clinical one, and small differences in how protocols are carried out are repeated across every scanner, shift and site. Our panel examines where variability enters the CT contrast workflow, why it persists and why optimizing CT contrast utilization is becoming increasingly important. 

U.S. Radiology departments navigating CT market challenges—supply disruptions and rising demand for contrast and delivery—need reliable partners. Hear Bayer leads explain how Bayer helps provide steady supply and innovations to support CT imaging and patient care.

As radiology departments across the US continue to navigate the complexities of the current imaging market, including disruptions in supply chains and increased demand for CT contrast media, one constant remains: the need for reliable, quality supply partners to help sustain patient care. 

Listen in now to this webinar that explores the MEDRAD® Centargo CT Injection System, Bayer’s multi-patient injector designed to enhance workflow efficiency in high-throughput CT suites.